An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

August 31, 2027

Conditions

Diffuse Large B Cell Lymphoma

Interventions

BIOLOGICAL

JWCAR201

Autologous CD19/CD20-directed CAR-T cells, single infusion intravenously

Trial Locations (1)

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER